Drugs / Xianglei Tangzu Gao
Xianglei Tangzu Gao
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06531512 | Aug 2024 → May 2026 overdue | ulcer of lower limbs | Oneness Biotech Co., Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xianglei Tangzu Gao | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06531512 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Active ingredients: Extracts of Plectranthus amboinicus and Centella Asiatica” NCT06531512 ↗ |
| Route | Topical | “will be applied twice daily for up to 16 weeks to the Target Ulcer” NCT06531512 ↗ |